4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-005261
Chief Operating Officer sold 169,500 shares at an average $13.54 ($2,295,805)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GIVEN BRUCE D Chief Operating Officer | 2019-01-22 | Sale | −152,000 | $13.59 | $2,065,680 | 916,356 | D |
| GIVEN BRUCE D Chief Operating Officer | 2019-01-23 | Sale | −17,500 | $13.15 | $230,125 | 898,856 | D |
| Open-market sales · 169,500 sh · avg $13.54 · $2,295,805 | |||||||
Loading xslF345X03/doc4.xml…